News

High Business Quality and Resilient Moat Drive Veeva Systems’ (VEEV) Long-Term Investment Conviction

Investment management company Vulcan Value Partners recently released its third-quarter 2026 investor letter. The letter can be downloaded here. The portfolio reported a strong quarter, with all strategies except Small Cap reporting positive absolute results, with Small Cap down about 1%. In the quarter, the Large Cap Composite (Net) returned 7.4%, the Small Cap Composite (Net) returned […]

Yahoo·09:52VEEV▼−1.5%

Veeva Systems (NYSE:VEEV): A Quality Stock With Durable Growth and a Premium Valuation

Veeva Systems passes a quality-investing screen on growth, profitability, low debt and cash conversion, but premium valuation remains the key risk.

ChartMill·05:01VEEV▼−1.5%

Baird Maintains Outperform on Veeva Systems, Raises Price Target to $350

Baird analyst Joe Vruwink maintains Veeva Systems (NYSE:VEEV) with a Outperform and raises the price target from $300 to $350.

Benzinga·03:16VEEV▼−1.5%

Is Veeva Systems Stock Really Expensive?

For questions about this article or underlying research, email help@trefis.com.

Yahoo·10:36VEEV▼−1.5%

Veeva Systems (VEEV) Rises Higher Than Market: Key Facts

In the most recent trading session, Veeva Systems (VEEV) closed at $316.8, indicating a +2.08% shift from the previous trading day.

Yahoo·16:50VEEV▼−1.5%

Barclays Maintains Overweight on Veeva Systems, Raises Price Target to $360

Barclays analyst Saket Kalia maintains Veeva Systems (NYSE:VEEV) with a Overweight and raises the price target from $315 to $360.

Benzinga·11:34VEEV▼−1.5%

Veeva Systems' Research and Development Growth Tracking to Plan, Oppenheimer Says

Veeva Systems' (VEEV) guidance implied a potential further deceleration for the company's research a

Yahoo·12:03VEEV▼−1.5%

Is Veeva (VEEV) a Buy as Wall Street Analysts Look Optimistic?

According to the average brokerage recommendation (ABR), one should invest in Veeva (VEEV). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?

Yahoo·08:30VEEV▼−1.5%

Veeva to Host Virtual Investor Day on November 5, 2026

Veeva Systems (NYSE: VEEV) will host its investor day virtually on Thursday, November 5, 2026. The event will begin at 1:30 p.m. PT and will conclude at approximately 3:30 p.m. PT.

Yahoo·16:05VEEV▼−1.5%

Is Veeva Systems (VEEV) Quietly Redefining Clinical Tech Moats With IQVIA Deal And Basics Uptake?

In recent days, IQVIA announced it has selected Veeva Systems’ CTMS, eTMF, Study Startup, and Site Connect as enterprise-standard applications across its clinical development studies, extending their earlier EDC partnership and making Veeva’s full clinical technology stack available to sponsors. At the same time, Veeva reported that more than 175 emerging biotechs are now using its Veeva Basics suite to build scalable, end-to-end digital foundations for clinical, regulatory, quality,...

Yahoo·15:17VEEV1.5%

Veeva Systems (VEEV) Becomes Default Clinical Software Across A Major Research Partner

Veeva Systems (NYSE:VEEV) said IQVIA will adopt Veeva's core clinical applications as enterprise standards across all IQVIA studies. The expanded agreement covers Veeva Clinical Trial Management System, eTMF, Study Startup, and Site Connect for IQVIA's global research operations. The move deepens Veeva's role in IQVIA's clinical execution workflow and broadens its reach across contract research and biopharma customers. IQVIA's decision to standardize on Veeva's clinical suite reshapes how...

Yahoo·14:15VEEV▼−1.5%

Veeva Stock Breaks Out As Big Money Grabs Exposure To The AI Software Play

Veeva Systems stock moves above a buy point in its early-stage chart pattern.

Yahoo·13:11VEEV▼1.5%

VEEV Expands IQVIA Partnership With Clinical Operations Software Suite

Veeva expands its IQVIA partnership with clinical operations software, boosting its market reach and growth prospects through wider adoption and integrated workflows.

Yahoo·09:44VEEV▼−1.5%

Jim Cramer Says Investors Who Bet AI Would Destroy Software Stocks ‘Blew Up’ — Salesforce, Veeva and Palantir Led Q3 Comeback: Stocks to Watch Ahead

Enterprise software's resurgence was a defining stock market story of the third quarter despite fears of AI negatively impacting their business, according to Jim Cramer.

Benzinga·01:07VEEV▼−1.5%

Veeva Systems (VEEV) Stock Declines While Market Improves: Some Information for Investors

Veeva Systems (VEEV) closed the most recent trading day at $281.93, moving 1.23% from the previous trading session.

Yahoo·16:50VEEV▼−1.5%

Veeva Systems Inc. (VEEV) Is a Trending Stock: Facts to Know Before Betting on It

Veeva (VEEV) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Yahoo·08:00VEEV▼−1.5%

Servier Adopts Veeva OpenData Globally to Scale AI

Veeva Systems (NYSE: VEEV) today announced that Servier is standardizing customer reference data across more than 80 countries with Veeva OpenData. Building on its global success with Veeva Link Key People, a leading French pharmaceutical company governed by a Foundation, is harmonizing customer reference data and creating a unified foundation to scale AI.

Yahoo·07:03VEEV▼−1.5%

Veeva Systems: Same Old Story, Same Rating Once Again

Veeva Systems faces significant headwinds as Salesforce ends their partnership and competitive threats limit upside potential. See why VEEV stock is a hold.

SeekingAlpha·00:24VEEV▼−1.5%

Brokers Suggest Investing in Veeva (VEEV): Read This Before Placing a Bet

Based on the average brokerage recommendation (ABR), Veeva (VEEV) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?

Yahoo·08:30VEEV▼−1.5%

Is Veeva Systems Stock Underperforming the Dow?

Veeva Systems has underperformed the Dow over the past year, but analysts are cautiously optimistic about the stock’s prospects.

Yahoo·07:54VEEV▼−1.5%

Veeva Systems: Excellent Execution, But Upside Potential Has Waned (Rating Downgrade)

Veeva Systems was downgraded to neutral after a 40%+ rally as valuation looks stretched despite strong growth and Falcon AI demand. Click for more on VEEV stock.

SeekingAlpha·02:25VEEV▼−1.5%

How Investors Are Reacting To Veeva Systems (VEEV) Expanding Agentic AI And Winning New Pharma Clients

In recent days, Veeva Systems has rolled out new AI-powered tools such as Veeva Study Builder Agent and Veeva Falcon Router, while announcing major customer wins including Oxford Biomedica adopting Veeva Quality Cloud and Amgen planning a global deployment of Veeva Vault CRM. Together, these developments highlight Veeva’s push to embed agentic AI across clinical, safety, quality, and commercial workflows, reinforcing its role as an end-to-end software partner for life sciences...

Yahoo·02:10VEEV▼−1.5%

Veeva Systems (VEEV) Could Be 29% Undervalued Following Its New AI Study Design Launch

Veeva Systems launches new AI study design agent Veeva Systems (VEEV) has unveiled Veeva Study Builder Agent, an AI tool that configures its EDC and Data Quality System directly from a clinical study protocol, aiming to streamline and standardize trial setup. Recent AI product launches and new client wins have arrived alongside a sharp 71.27% 90 day share price return and an 8.97% 30 day share price return for Veeva Systems, while the 1 year total shareholder return is slightly down 2.59%,...

Yahoo·13:11VEEV▼−1.5%

New Veeva Study Builder Agent to Configure Clinical Studies in as Little as One Day

Veeva Systems (NYSE: VEEV) today announced Veeva Study Builder Agent, a new AI solution that configures Veeva EDC and Veeva DQS (Data Quality System) directly from a study protocol. By reusing an organization's existing standards and leveraging the CDISC Unified Study Definitions Model (USDM), the agent ensures faster, more deterministic study builds.

Yahoo·07:03

Veeva Unveils Falcon Router to Streamline Biopharma Case Routing

VEEV launches Falcon Router to automate biopharma case routing, deepening AI integration across regulated life sciences workflows.

Yahoo·13:02VEEV▼−1.5%

Vault CRM Extends Market Leadershipas Another Top 20 Biopharma Chooses Veeva

Veeva Systems (NYSE: VEEV) today announced a new top 20 biopharma commitment, adding to recent selections by Amgen, Biogen, Eli Lilly and Company, and Regeneron. With more than 190 live customers and global commitments from 14 of the top 20 biopharmas, Vault CRM is the next generation of CRM, delivering new agentic and core capabilities to increase field productivity and effectiveness.

Yahoo·07:03VEEV▼−1.5%

Pharmacovigilance Software Market Size, Share & Trends Analysis - Global Opportunity Analysis and Industry Forecast (2026-2036)

The global pharmacovigilance software market is projected to grow from USD 4.5 billion in 2026 to USD 12.7 billion by 2036, at a 10.9% CAGR. Growth is driven by stricter drug safety regulations, expanding clinical trials, rising adverse event data, and adoption of AI, automation, NLP and cloud platforms. North America leads the market, while Asia-Pacific will grow fastest. Key players include Oracle, IQVIA, ArisGlobal, Parexel, ICON, Veeva Systems and RxLogix.Dublin, Sept. 23, 2026 (GLOBE NEWSWI

Yahoo·05:57VEEV▼−1.5%

Here's How Much a $1000 Investment in Veeva Systems Made 10 Years Ago Would Be Worth Today

Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.

Yahoo·08:30VEEV▼−1.5%

Veeva Expands Amgen Partnership With Global Vault CRM Rollout Plan

VEEV expands its decade-long Amgen partnership with a global Vault CRM rollout, reinforcing enterprise adoption and commercial subscription growth.

Yahoo·13:04VEEV▼−1.5%

Veeva Introduces Falcon Router for Agentic Triage of All Reporting Channels

Veeva Systems (NYSE: VEEV) today announced Veeva Falcon Router, an industry-specific agent to identify and route potential safety adverse event reports, product quality complaints, and medical inquiries to the correct teams with speed and consistency.

Yahoo·07:03VEEV▼−1.5%

Veeva Launches AI Agent To Speed Up Safety And Medical Request Routing

Veeva Systems (NYSE:VEEV) today announced Veeva Falcon Router, an industry-specific agent to identify and route potential safety adverse event reports, product quality complaints, and medical inquiries to the correct

Benzinga·03:11VEEV▼−1.5%

Trade Desk (TTD) Expands Healthcare Data Ties, Is The Stock Still Undervalued?

Trade Desk’s healthcare data push Trade Desk (TTD) is back in focus after expanding its integrations with healthcare data specialists Veeva Systems and IQVIA, giving pharma advertisers more granular campaign insights directly inside its advertising platform. Recent trading has been rough for Trade Desk, with the share price down 24.8% over the past 90 days and the year-to-date share price return declining 63.1%, while the 1-year total shareholder return is down 68.7%. This points to fading...

Yahoo·05:11VEEV▼−1.5%

2 Profitable Stocks to Keep an Eye On and 1 We Ignore

Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.

Yahoo·06:00

Investors Heavily Search Veeva Systems Inc. (VEEV): Here is What You Need to Know

Veeva (VEEV) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Yahoo·09:00VEEV▼−1.5%

Veeva Systems (NYSE:VEEV) Combines Strong Growth With a High-Quality Technical Setup

VEEV pairs strong growth, elite profitability, and a debt-free balance sheet with a constructive technical setup, though rich valuation remains a risk.

ChartMill·05:00VEEV▼−1.5%

2 Reasons to Like VEEV (and 1 Not So Much)

What a fantastic six months it’s been for Veeva Systems. Shares of the company have skyrocketed 43%, hitting $265. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.

Yahoo·13:03VEEV▼−1.5%

Veeva Systems (VEEV) Just Flashed Golden Cross Signal: Do You Buy?

When a stock breaks out above the 20-day simple moving average, good things could be on the horizon. How should investors react?

Yahoo·09:35VEEV▼−1.5%

Veeva Systems (NYSE:VEEV) Exhibits Strong Growth and Bull Flag Breakout Potential

Veeva Systems combines strong fundamentals with a bullish technical breakout setup, making it a compelling growth stock pick.

ChartMill·06:31VEEV▼−1.5%

Piper Sandler Assumes Veeva Systems at Overweight, Raises Price Target to $295

Piper Sandler analyst Billy Fitzsimmons assumes Veeva Systems (NYSE:VEEV) with a Overweight rating and raises Price Target to $295.

Benzinga·07:23VEEV▼−1.5%

Needham Reiterates Buy on Veeva Systems, Maintains $270 Price Target

Needham analyst Ryan MacDonald reiterates Veeva Systems (NYSE:VEEV) with a Buy and maintains $270 price target.

Benzinga·02:10VEEV▼−1.5%

Veeva (VEEV) Stock Fair Value Edges Higher As Analysts Weigh AI And CRM Risks

The analyst derived fair value estimate for Veeva Systems has moved from US$245.48 to US$251.43 per share, signalling a modest reset in how the stock is being valued. This shift sits against a backdrop of mixed commentary, with some firms pointing to Q1 and Q2 execution, AI initiatives and CRM wins, while others focus on AI disruption risk, CRM competition and questions about the quality of recent upside. As you read on, you will see how to track these changing views and what to watch as the...

Yahoo·06:08VEEV▼−1.5%

Will Eli Lilly’s Global Vault CRM Deal and Leadership Shift Change Veeva Systems’ (VEEV) Narrative?

Veeva Systems recently secured Eli Lilly and Company’s commitment to deploy Veeva Vault CRM globally, while also announcing that President and Chief Customer Officer Thomas D. Schwenger will depart in October 2026, to be succeeded by Dan Rizzo as EVP of Sales, Consulting, and Services. These developments arrive as Wall Street analysts anticipate higher upcoming quarterly earnings and revenue for Veeva, highlighting how large client wins and leadership transitions could shape the company’s...

Veeva (VEEV) Stock Looks To Trade At A Premium Following A 34% Run

Veeva Systems has surged over the past month, yet its valuation checks are sending mixed signals, with an intrinsic value estimate based on a Discounted Cash Flow (DCF) model pointing to upside, while traditional market multiples look less generous. The stock is up 34.3% over the past month, which raises the bar for any new buyers looking for a clear margin of safety. Expectations around ongoing revenue growth and earnings strength, helped by new customer wins and contract renewals, can...

Yahoo·04:12VEEV▼−1.5%

Veeva Systems (VEEV) Names Dan Rizzo EVP Of Sales Consulting And Services

Veeva Systems (NYSE:VEEV) announced a leadership transition with Dan Rizzo appointed EVP, Sales, Consulting, and Services. Long-serving executive Thomas D. Schwenger is leaving Veeva to become CEO at a partner company. The changes affect oversight of Veeva's global sales, consulting, and services organization. This kind of leadership reshuffle is not unique to Veeva Systems, so it can be useful to compare it with other companies exposed to similar themes of management change and execution...

Yahoo

Veeva (VEEV) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

Besides Wall Street's top-and-bottom-line estimates for Veeva (VEEV), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended July 2026.

Yahoo·10:15VEEV▼−1.5%

1 Cash-Producing Stock Worth Investigating and 2 We Find Risky

While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.

Yahoo·06:31

Guggenheim Maintains Buy on Veeva Systems, Raises Price Target to $276

Guggenheim analyst Tamjid Chowdhury maintains Veeva Systems (NYSE:VEEV) with a Buy and raises the price target from $232 to $276.

Benzinga·05:17VEEV▼−1.5%

Do Wall Street Analysts Like Veeva Systems Stock?

Veeva Systems has underperformed the broader market amid softer demand and competition, while analysts remain moderately optimistic about its future prospects.

Yahoo·08:24VEEV▼−1.5%

Barclays Maintains Overweight on Veeva Systems, Raises Price Target to $275

Barclays analyst Saket Kalia maintains Veeva Systems (NYSE:VEEV) with a Overweight and raises the price target from $235 to $275.

Benzinga·05:30VEEV▼−1.5%

Oppenheimer Maintains Outperform on Veeva Systems, Raises Price Target to $300

Oppenheimer analyst Ken Wong maintains Veeva Systems (NYSE:VEEV) with a Outperform and raises the price target from $225 to $300.

Benzinga·05:52VEEV▼−1.5%

Veeva Systems To Rally Around 13%? Here Are 10 Top Analyst Forecasts For Monday

Top analysts changed outlook on top names. For all changes, see analyst ratings page. AVBP $47, PGR $200, AEP $139, INTU $430, BCSF $13, GEMI $6, VEEV $275.

Benzinga·05:01VEEV▼−1.5%

Stifel Maintains Buy on Veeva Systems, Raises Price Target to $275

Stifel analyst David Grossman maintains Veeva Systems (NYSE:VEEV) with a Buy and raises the price target from $230 to $275.

Benzinga·03:47VEEV▼−1.5%

Gossamer Bio (GOSS) Reports Q2 Loss, Tops Revenue Estimates

Gossamer Bio (GOSS) delivered earnings and revenue surprises of -100.00% and +171.71%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Yahoo·17:15

Veeva Systems (VEEV) Exceeds Market Returns: Some Facts to Consider

Veeva Systems (VEEV) reached $241.51 at the closing of the latest trading day, reflecting a +2.08% change compared to its last close.

Yahoo·17:45VEEV▼−1.5%

Veeva Vault CRM Selected by Eli Lilly and Company

Veeva Systems (NYSE: VEEV) today announced that Eli Lilly and Company (Lilly) has committed to Veeva Vault CRM globally.

Yahoo·07:03VEEV▼−1.5%

Hims & Hers Health, Inc. (HIMS) Reports Q2 Loss, Tops Revenue Estimates

Hims & Hers Health (HIMS) delivered earnings and revenue surprises of -42.86% and +9.13%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Yahoo·17:55

What Is Behind Veeva Systems (VEEV) Latest Move?

Broker Signals On Veeva Systems Stock A fresh wave of brokerage opinions on Veeva Systems (VEEV) has put the stock back in focus for investors, as firms update their views using earnings estimate revisions and quantitative rating models. These ratings and the underlying Zacks Rank approach do not guarantee any outcome for Veeva Systems investors. They do, however, give you a structured way to compare fresh earnings expectations with the company’s recent share price moves. See our latest...

Yahoo·17:09VEEV▼−1.5%

Wall Street Bulls Look Optimistic About Veeva (VEEV): Should You Buy?

Based on the average brokerage recommendation (ABR), Veeva (VEEV) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?

Yahoo·09:30VEEV▼−1.5%